Bristol-Myers Off The Hook In Plavix Probe
Bristol-Myers Squibb Co. said a federal investigation found no violations of securities laws stemming from the company's actions in negotiating a patent settlement over blockbuster drug Plavix last year....To view the full article, register now.
Already a subscriber? Click here to view full article